Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VICTORION-CHALLENGE: Inclisiran vs Bempedoic Acid in ASCVD
NCT06431763Phase 4Completed
- Sponsor
- Novartis
- Start
- Jun 2024
- Primary completion
- Dec 2025
- Modality
- Antisense DNA, Conjugated siRNA, MicroRNA (miRNA)
- Countries
- 1
01
Overview
A Phase 4 trial of inclisiran in hypercholesterolemia, sponsored by Novartis. Started Jun 2024; status: completed.
02
Drugs
inclisiran
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT06431763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06431763.